General Information of Drug (ID:
DR3287) |
Drug Name |
E7016
|
Synonyms |
UNII-M8926C7ILX; E-7016; M8926C7ILX; 902128-92-1; E7016; SCHEMBL1319757; CHEMBL3527000; BDBM97563; GPI 21016; GPI-21016; SB16889; Benzopyrano(4,3,2-de)phthalazin-3(2H)-one, 10-((4-hydroxy-1-piperidinyl)methyl)-; US8470825, 4i; E 7016
|
Indication |
Melanoma
[ICD11: 2C30]
|
Phase 2
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
349.4 |
Topological Polar Surface Area |
74.2 |
Heavy Atom Count |
26 |
Rotatable Bond Count |
2 |
Hydrogen Bond Donor Count |
2 |
Hydrogen Bond Acceptor Count |
5 |
Cross-matching ID |
- PubChem CID
- 11660296
- CAS Number
-
- TTD Drug ID
- D06DHB
- Formula
- C20H19N3O3
- Canonical SMILES
- C1CN(CCC1O)CC2=CC3=C(C=C2)OC4=CC=CC5=C4C3=NNC5=O
- InChI
- InChI=1S/C20H19N3O3/c24-13-6-8-23(9-7-13)11-12-4-5-16-15(10-12)19-18-14(20(25)22-21-19)2-1-3-17(18)26-16/h1-5,10,13,24H,6-9,11H2,(H,22,25)
- InChIKey
- HAVFFEMDLROBGI-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.